全文获取类型
收费全文 | 580篇 |
免费 | 34篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 30篇 |
妇产科学 | 17篇 |
基础医学 | 77篇 |
口腔科学 | 5篇 |
临床医学 | 34篇 |
内科学 | 184篇 |
皮肤病学 | 19篇 |
神经病学 | 39篇 |
特种医学 | 11篇 |
外科学 | 80篇 |
预防医学 | 43篇 |
眼科学 | 11篇 |
药学 | 25篇 |
中国医学 | 1篇 |
肿瘤学 | 44篇 |
出版年
2024年 | 2篇 |
2023年 | 6篇 |
2022年 | 15篇 |
2021年 | 18篇 |
2020年 | 24篇 |
2019年 | 23篇 |
2018年 | 13篇 |
2017年 | 21篇 |
2016年 | 25篇 |
2015年 | 22篇 |
2014年 | 29篇 |
2013年 | 29篇 |
2012年 | 47篇 |
2011年 | 51篇 |
2010年 | 34篇 |
2009年 | 17篇 |
2008年 | 34篇 |
2007年 | 44篇 |
2006年 | 44篇 |
2005年 | 45篇 |
2004年 | 23篇 |
2003年 | 20篇 |
2002年 | 20篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 6篇 |
1998年 | 3篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1991年 | 1篇 |
排序方式: 共有623条查询结果,搜索用时 0 毫秒
621.
Kalliopi Michoglou Amsajini Ravinthiranathan Saw San Ti Saoirse Dolly Kiruthikah Thillai 《World Journal of Clinical Cases》2023,11(12):2631-2636
Pancreatic cancer is a highly devastating disease with high mortality rates. Even patients who undergo potential curative surgery have a high risk for recurrence. The incidence of depression and anxiety are higher in patients with cancer than the general population. However, patients with pancreatic cancer are at most of risk of both depression and anxiety and there seems to be a biological link. In some patients, depression seems to be a precursor to pancreatic cancer. In this article we discuss the biological link between depression anxiety and hepatobiliary malignancies and discuss treatment strategies. 相似文献
622.
George Papatheodoridis Konstantinos Mimidis Spilios Manolakopoulos Christos Triantos Ioannis Vlachogiannakos Christos Veretanos Melanie Deutsch Stylianos Karatapanis Ioannis Goulis Ioannis Elefsiniotis Evangelos Cholongitas Vassilios Sevastianos Dimitrios Christodoulou Dimitrios Samonakis Emanuel Manesis Andreas Kapatais Nikolaos Papadopoulos Panagiota Ioannidou Georgios Germanidis George Giannoulis Dimitra Lakiotaki Dionysios Kogias Ηarikleia Kranidioti Konstantinos Zisimopoulos Maria Mela George Kontos Paraskevi Fytili Chrysanthi Manolaka Polyxeni Agorastou Spyridon I. Pantzios Margarita Papatheodoridi Dimitrios Karagiannakis Eleni Geladari Nikolaos Psychos Kalliopi Zachou Anna Chalkidou Anastasia Spanoudaki Konstantinos Thomopoulos George Dalekos 《Liver international》2023,43(9):1879-1889
Background and Aims
Hepatitis D virus (HDV) underdiagnosis remains common. We assessed the HDV screening and prevalence rates in HBsAg-positive patients seen at tertiary liver centres throughout Greece as well as factors affecting HDV diagnosis.Methods
All adult HBsAg-positive patients seen within the last 5 years were included. Non-screened patients who visited or could be recalled to the clinics over a 6-month period were prospectively tested for anti-HDV.Results
Of 5079 HBsAg-positive patients, 53% had anti-HDV screening (41% before and 12% after study initiation). Pre-study (8%–88%) and total screening rates (14%–100%) varied widely among centres. Screening rates were associated with older age, known risk group, elevated ALT, centre location and size and period of first visit. Anti-HDV prevalence was 5.8% without significant difference in patients screened before (6.1%) or after study initiation (4.7%, p = 0.240). Anti-HDV positivity was associated with younger age, parenteral drug use, born abroad, advanced liver disease and centre location. Overall, HDV RNA detectability rate was 71.6% being more frequent in anti-HDV-positive patients with elevated ALT, advanced liver disease and hepatitis B therapy.Conclusions
Anti-HDV screening rates and recall capabilities vary widely among Greek liver clinics being higher in HBsAg-positive patients of known risk group with active/advanced liver disease seen at smaller centres, while non-medical factors are also important. Anti-HDV prevalence varies throughout Greece being higher in patients born abroad with younger age, parenteral drug use and advanced liver disease. Viremia is more frequently but not exclusively detected in anti-HDV-positive patients with elevated ALT and advanced liver disease. 相似文献623.